Anaveon Funding: $156M Raised, Series B (2021)

Anaveon funding overview

Anaveon is based in Basel, Switzerland. Anaveon has raised $156M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2021. The round record for Anaveon runs through 2021; nothing later has been disclosed. Investors on record include Forbion, Syncona, Novartis Venture Fund, Cowen Healthcare Investments, Pfizer Ventures, Pontifax and 2 others. 8 distinct backers are named across the disclosed rounds.

Anaveon at a glance

Total raised: $156M
Latest round: Series B
Latest round date: December 2021
Headquarters: Basel, Switzerland
Notable investors: Forbion, Syncona, Novartis Venture Fund, Cowen Healthcare Investments, Pfizer Ventures, Pontifax, BaseLaunch, University of Zurich Life Sciences Fund

Frequently asked about Anaveon funding

How much has Anaveon raised?: Anaveon has raised $156M in total disclosed funding across the rounds on record.
Who has invested in Anaveon?: Forbion, Syncona, Novartis Venture Fund, Cowen Healthcare Investments, Pfizer Ventures, Pontifax are named among the investors backing Anaveon.
What was the latest Anaveon funding round?: The most recent disclosed round is a Series B, announced in December 2021.
Where is Anaveon based?: Anaveon is based in Basel, Switzerland.
When did Anaveon last raise?: The last disclosed Anaveon round closed in December 2021 at Series B.

Totals shown for Anaveon aggregate every disclosed round on file. To see how that compares, browse the companies in Basel and the investors behind them below.

Anaveon Funding: $156M Raised, Series B (2021)

Anaveon funding overview

Anaveon at a glance

Frequently asked about Anaveon funding

Companies related to Anaveon (33)

Browse related funding lists (9)